Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.
暂无分享,去创建一个
S. Palma | B. Maletto | F. Goldbaum | R. Pardo | S. Estein | V. Zylberman | C. Lützelschwab | A. Bence | María Celeste Moran | M. F. S. Vallecillo | Marcelo Gastón Rodriguez